share_log

AbbVie | 8-K: AbbVie Inc. Guidance Including the Impact of Acquired IPR&D and Milestones Expense

AbbVie | 8-K: AbbVie Inc. Guidance Including the Impact of Acquired IPR&D and Milestones Expense

艾伯維公司 | 8-K:艾伯維公司指導方針包括收購知識產權研發和裏程碑支出的影響
美股sec公告 ·  07/03 14:10
Moomoo AI 已提取核心訊息
Sorry, I'm currently unable to summarize this unique file format. However, I will aim to learn it for next time.
Sorry, I'm currently unable to summarize this unique file format. However, I will aim to learn it for next time.
抱歉,我目前無法概括這種獨特的文件格式。但是,我會努力學習,以備下一次。
抱歉,我目前無法概括這種獨特的文件格式。但是,我會努力學習,以備下一次。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息